Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease

被引：12
|
作者：
Bibbins-Domingo, K
Feng, L
Vittinghoff, E
Barrett-Connor, E
Hulley, SB
Grady, D
Shlipak, MG
机构：
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA USA
[4] Univ Calif San Francisco, Vet Adm Med Ctr, Sect Gen Med, San Francisco, CA USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 95卷 / 02期
关键词：
D O I：
10.1016/j.amjcard.2004.09.021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Randomized, controlled trial data from the Heart and Estrogen-progestin Replacement Study were used to evaluate the effect of estrogen plus progestin use on all-cause mortality in women with heart failure and coronary disease. Over the 4.1-year follow-up, estrogen plus progestin use had no effect on all-cause mortality (hazard ratio 1.0, 95% confidence interval 0.7 to 1.4, p = 0.8) in women with heart failure and coronary disease. (C) 2005 by Excerpta Medica Inc.
引用
收藏
页码：289 / 291
页数：3
相关论文
共 50 条
  • [1] The Heart of the Matter Women, Coronary Artery Disease, and Heart Failure
    Barghash, Maya H.
    [J]. JACC-HEART FAILURE, 2023, 11 (12) : 1664 - 1665
  • [2] Hormone therapy and coronary heart disease in young women
    Weiner, Mark G.
    Barnhart, Kurt
    Xie, Dawei
    Tannen, Richard L.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (01): : 86 - 93
  • [3] Coronary heart disease in women: Hormone replacement therapy
    Mary S. Beattie
    Rita Redberg
    [J]. Current Treatment Options in Cardiovascular Medicine, 2002, 4 (2) : 129 - 136
  • [4] Heart failure therapy in patients with coronary artery disease
    Taylor, Clare J.
    Hobbs, F. D. Richard
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (02) : 205 - 209
  • [5] Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure
    Bunch, TJ
    Muhlestein, JB
    Bair, TL
    Renlund, DG
    Lappé, DL
    Jensen, KR
    Horne, BD
    Carter, MA
    Anderson, JL
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (07): : 827 - 831
  • [6] Metabolomic Effects of Hormone Therapy and Associations With Coronary Heart Disease Among Postmenopausal Women
    Balasubramanian, Raji
    Demler, Olga
    Guasch-Ferre, Marta
    Paynter, Nina P.
    Sheehan, Ryan
    Liu, Simin
    Manson, JoAnn E.
    Salas-Salvado, Jordi
    Martinez-Gonzalez, Miguel a.
    Hu, Frank B.
    Clish, Clary
    Rexrode, Kathryn M.
    [J]. CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (06): : 618 - 629
  • [7] Age, hormone therapy use, coronary heart disease, and mortality
    Allison, Matthew A.
    Manson, JoAnn E.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (03): : 243 - 245
  • [8] Predictors of heart failure among women with coronary disease
    Bibbins-Domingo, K
    Lin, F
    Vittinghoff, E
    Barrett-Connor, E
    Hulley, SB
    Grady, D
    Shlipak, MG
    [J]. CIRCULATION, 2004, 110 (11) : 1424 - 1430
  • [9] National rates of antiplatelet therapy in Medicare beneficiaries with heart failure and coexisting coronary artery disease
    Masoudi, FA
    Havranek, EP
    Wolfe, P
    Westfall, KA
    Ordin, DL
    Krumholz, HM
    [J]. AMERICAN HEART JOURNAL, 2002, 144 (05) : 916 - 916
  • [10] Coronary Heart Disease Mortality and Hormone Therapy Before and After the Women's Health Initiative
    Tuomikoski, Pauliina
    Lyytinen, Heli
    Korhonen, Pasi
    Hoti, Fabian
    Vattulainen, Pia
    Gissler, Mika
    Ylikorkala, Olavi
    Mikkola, Tomi S.
    [J]. OBSTETRICS AND GYNECOLOGY, 2014, 124 (05): : 947 - 953
12345